The association between apolipoprotein e gene polymorphisms and essential hypertension: A meta-analysis of 45 studies including 13 940 cases and 16 364 controls

Journal of Human Hypertension

Volumn 27, Issue 4, 2013, Pages 245-255

  Stoumpos, S ^a   Hamodrakas, S J ^a   Anthopoulos, P G ^a   Bagos, P G ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF CENTRAL GREECE   (Greece)

Author keywords

apolipoprotein E; meta analysis; polymorphism; random effects

Indexed keywords

APOLIPOPROTEIN E;

ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LATITUDE; META ANALYSIS; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 84875223853     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2012.37     Document Type: Article

References (67)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh J, Brenner B (eds). Hypertension-Pathophysiology, Diagnosis and Management. Raven Press: New York, 1990, pp 81.
2. Shore VG, Shore B. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry 1973; 12(3): 502-507.
3. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41(8 Pt 1): 1068-1086.
4. Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14(8): 2084-2091.
5. Zak I, Niemiec P, Balcerzyk A, Krauze J. Combined 'pro-atherosclerotic' variants of the ACE and APOE genes increase the risk of the coronary artery disease associated with the presence of cigarette smoking. Acta Cardiol 2008; 63(6): 741-747.
6. Pan Z, Trikalinos TA, Kavvoura FK, Lau J, Ioannidis JP. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Med 2005; 2(12): e334.
7. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-2012.
8. Bagos PG. A unification of multivariate methods for meta-analysis of genetic association studies. Stat Appl Genet Mol Biol 2008; 7(1): Article31.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-188.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-560.
11. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999; 18(20): 2693-2708.
12. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50(4): 1088-1101.
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-634.
14. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 2006; 163(4): 300-309.
15. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48(2): 361-372.
16. Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995; 48(1): 45-57, discussion 59-60.
17. Ioannidis JP, Trikalinos TA. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 2005; 58(6): 543-549.
18. Bagos PG, Nikolopoulos GK. Generalized least squares for assessing trends in cumulative meta-analysis with applications in genetic epidemiology. J Clin Epidemiol 2009; 62(10): 1037-1044.
19. Terry JG, Howard G, Mercuri M, Bond MG, Crouse 3rd Jr. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke 1996; 27(10): 1755-1759.
20. Djousse L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G et al. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 2002; 33(5): 1357-1361.
21. Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol Aging 2009; 30(6): 946-956.
22. Fuzikawa AK, Peixoto SV, Taufer M, Moriguchi EH, Lima-Costa MF. Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambui Health Aging Study (BHAS). Braz J Med Biol Res 2008; 41(2): 89-94.
23. Resnick HE, Rodriguez B, Havlik R, Ferrucci L, Foley D, Curb JD et al. Apo E genotype, diabetes, and peripheral arterial disease in older men: the Honolulu Asia-aging study. Genet Epidemiol 2000; 19(1): 52-63.
24. Profenno LA, Faraone SV. Diabetes and overweight associate with non-APOE4 genotype in an Alzheimer's disease population. Am J Med Genet B Neuropsychiatr Genet 2008; 147B(6): 822-829.
25. Carmelli D, Swan GE, Reed T, Miller B, Wolf PA, Jarvik GP et al. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 1998; 50(6): 1580-1585.
26. Bennouar N, Allami A, Laraqui A, Azeddoug H, El-Kadiri N, Benkouka F et al. [Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease]. Ann Biol Clin 2004; 62(3): 295-304.
27. Carmo MM, Lima FL, Rodrigues MO, Albergaria I, Fonseca A. Influence of the APOE genotypes in some atherosclerotic risk factors. Acta Med Port 2008; 21(5): 433-440.
28. Isbir T, Yilmaz H, Bihorac A, Akoglu E. Mild-to-moderate hypertension and apoli-poprotein E gene polymorphism. Am J Hypertens 1997; 10(7 Part 1): 827-828.
29. Corbo RM, Vilardo T, Ruggeri M, Gemma AT, Scacchi R. Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population. Clin Biochem 1999; 32(3): 217-222.
30. Yilmaz H, Isbir T, Agachan B, Aydin M. Is epsilon4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? Cell Biochem Funct 2001; 19(3): 191-195.
31. Li X, Du Y, Huang X. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2003; 2(4): 175-179.
32. Niu W, Guo X, Su Y, Qiu C. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension. J Hum Hypertens 2007; 21(4): 337-339.
33. Dembinska-Kiec A, Kawecka-Jaszcz K, Kwasniak M, Guevara I, Pankiewicz J, Malczewska-Malec M et al. Apo E isoforms, insulin output and plasma lipid levels in essential hypertension. Eur J Clin Invest 1998; 28(2): 95-99.
34. Eto M, Watanabe K, Chonan N, Ishii K. Familial hypercholesterolemia and apoli-poprotein E4. Atherosclerosis 1988; 72(2-3): 123-128.
35. Niu W, Qi Y, Qian Y, Gao P, Zhu D. The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res 2009; 32(12): 1060-1066.
36. Niu WQ, Qi Y. Meta-based evidence for apolipoprotein E varepsilon2/varepsilon3/varepsilon4 polymorphism in association with hypertension among Chinese. J Hum Hypertens 2011; 25(12): 725-731.
37. Conn VS, Valentine JC, Cooper HM, Rantz MJ. Grey literature in meta-analyses. Nurs Res 2003; 52(4): 256-261.
38. Young JH, Chang YP, Kim JD, Chretien JP, Klag MJ, Levine MA et al. Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion. PLoS Genet 2005; 1(6): e82.
39. Karvonen J, Kauma H, Kervinen K, Ukkola O, Rantala M, Paivansalo M et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 2002; 20(12): 2371-2378.
40. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Cerebrovascular disease, the apo-lipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27(12): 2230-2235.
41. Schmidt R, Schmidt H, Fazekas F, Schumacher M, Niederkorn K, Kapeller P et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 1997; 28(5): 951-956.
42. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R et al. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 1997; 17(11): 2880-2884.
43. Kimura H, Suzuki Y, Gejyo F, Karasawa R, Miyazaki R, Suzuki S et al. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis 1998; 31(4): 666-673.
44. Niemi M, Kervinen K, Rantala A, Kauma H, Paivansalo M, Savolainen MJ et al. The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects. Gut 1999; 44(4): 557-562.
45. Dzimiri N, Meyer BF, Hussain SS, Basco C, Afrane B, Halees Z. Relevance of apo-lipoprotein E polymorphism for coronary artery disease in the Saudi population. Arch Pathol Lab Med 1999; 123(12): 1241-1245.
46. Meigs JB, Ordovas JM, Cupples LA, Singer DE, Nathan DM, Schaefer EJ et al. Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care 2000; 23(5): 669-674.
47. Gonzalez-Amieva A, Lopez-Miranda J, Fuentes F, Castro P, Marin C, Lopez-Granados A et al. Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation. J Heart Lung Transplant 2000; 19(8): 765-770.
48. Guz G, Nurhan Ozdemir F, Sezer S, Isiklar I, Arat Z, Turan M et al. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis 2000; 36(4): 826-836.
49. Imazu M, Yamamoto H, Toyofuku M, Watanabe T, Okubo M, Egusa G et al. Association of apolipoprotein E phenotype with hypertension in Japanese-Americans: data from the Hawaii-Los Angeles-Hiroshima Study. Hypertens Res 2001; 24(5): 523-529.
50. Bednarska-Makaruk M, Broda G, Kurjata P, Rodo M, Roszczynko M, Rywik S et al. Apolipoprotein E genotype, lipid levels and coronary heart disease in a Polish population group. Eur J Epidemiol 2001; 17(8): 789-792.
51. Schwanke CH, da Cruz IB, Leal NF, Scheibe R, Moriguchi Y, Moriguchi EH. Analysis of the association between apolipoprotein E polymorphism and cardiovascular risk factors in an elderly population with longevity. Arq Bras Cardiol 2002; 78(6): 561-579.
52. Katsuya T, Baba S, Ishikawa K, Mannami T, Fu Y, Inamoto N et al. Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study. J Hypertens 2002; 20(10): 2017-2021.
53. Mozas P, Castillo S, Reyes G, Tejedor D, Civeira F, Garcia-Alvarez I et al. Apolipo-protein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia. Am Heart J 2003; 145(6): 999-1005.
54. Qiu C, Winblad B, Fastbom J, Fratiglioni L. Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. Neurology 2003; 61(5): 655-660.
55. Pezzini A, Grassi M, Del Zotto E, Bazzoli E, Archetti S, Assanelli D et al. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke 2004; 35(2): 438-442.
56. de Leeuw FE, Richard F, de Groot JC, van Duijn CM, Hofman A, Van Gijn J et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004; 35(5): 1057-1060.
57. Ranjith N, Pegoraro RJ, Rom L, Rajput MC, Naidoo DP. Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction. Cardiovasc J S Afr 2004; 15(3): 111-117.
58. Kang JH, Logroscino G, De Vivo I, Hunter D, Grodstein F. Apolipoprotein E cardiovascular disease and cognitive function in aging women. Neurobiol Aging 2005; 26(4): 475-484.
59. Um JY, Hwang CY, Hwang WJ, Kang SD, Do KR, Cho JJ et al. Association between iris constitution and apolipoprotein e gene polymorphism in hypertensives. J Altern Complement Med 2004; 10(6): 1101-1105.
60. Bhavani AB, Sastry KB, Reddy NK, Padma T. Lipid profile and apolipoprotein E polymorphism in essential hypertension. Indian Heart J 2005; 57(2): 151-157.
61. Rowan E, Morris CM, Stephens S, Ballard C, Dickinson H, Rao H et al. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects 475 years of age. Stroke 2005; 369: 1864-1868.
62. Pitsavos C, Choumerianou DM, Skoumas J, Maumus S, Stefanadis C, Dedoussis GV et al. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia. Clin Exp Med 2005; 5(4): 196-201.
63. Baum L, Lam LC, Kwok T, Lee J, Chiu HF, Mok VC et al. Apolipoprotein E epsilon4 allele is associated with vascular dementia. Dement Geriatr Cogn Disord 2006; 22(4): 301-305.
64. Formiga F, Alia P, Navarro MA, Pujol R. Apolipoprotein e genotypes in nonagenarians. J Am Geriatr Soc 2006; 54(9): 1471-1473.
65. Wohlin M, Sundstrom J, Lannfelt L, Axelsson T, Syvanen AC, Andren B et al. Apolipoprotein E epsilon4 genotype is independently associated with increased intima-media thickness in a recessive pattern. Lipids 2007; 42(5): 451-456.
66. Wang B, Zhao H, Zhou L, Dai X, Wang D, Cao J et al. Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese. J Neurol Sci 2009; 276(1-2): 118-122.
67. Ruixing Y, Jinzhen W, Weixiong L, Yuming C, Dezhai Y, Shangling P. The environmental and genetic evidence for the association of hyperlipidemia and hypertension. J Hypertens 2009; 27(2): 251-258.